Pablo Luis Ortiz R.
- Country
- Spain
- Department
- Dermatology
Research Overview
- Evaluation of a Drug Combination in Patients with Cutaneous T-cell Lymphomas (CTCL)
- Adjuvant Pembrolizumab Versus Placebo in High-Risk Stage III Melanoma Post-Resection: A Randomized, Double-Blind Phase 3 EORTC Trial
- Phase II Evaluation of Lacutamab Monotherapy and Combination Chemotherapy in Advanced T-Cell Lymphomas, Including Sézary Syndrome and Mycosis Fungoides
Data & Insights
Has run more than one trial at 43 of 169 partner sites.
Specializations
Oncologic Dermatology and Skin Cancer
Clinical research in Dermatology with a strong focus on skin cancer, including cutaneous squamous cell carcinoma, basal cell carcinoma, melanoma, and cutaneous T-cell lymphoma. The portfolio also includes interest in inflammatory and immune-mediated skin disease.
- Basal cell carcinoma
- Cutaneous squamous cell carcinoma
- Melanoma
- Cutaneous T-cell lymphoma
Work in this area links dermatologic oncology with targeted and immunologic treatment strategies for advanced and recurrent disease.
Inflammatory Skin Disease and Autoimmunity
Research activity extends across chronic inflammatory dermatoses and systemic immune disorders, with attention to atopic dermatitis, psoriasis, hidradenitis suppurativa, bullous pemphigoid, and vitiligo, alongside broader autoimmune disease involvement.
- Atopic dermatitis
- Psoriasis
- Hidradenitis suppurativa
- Bullous pemphigoid
This domain reflects engagement with immune-mediated skin conditions that require long-term control and steroid-sparing therapeutic options.
Breast, Gynecologic, and Urothelial Malignancies
The investigator is involved in studies across major solid tumors, especially breast cancer, ovarian cancer, endometrial cancer, cervical cancer, and urothelial carcinoma, with additional interest in prostate cancer and renal cell carcinoma.
- Breast cancer
- Ovarian cancer
- Endometrial cancer
- Urothelial carcinoma
The therapeutic emphasis includes biomarker-directed treatment and disease-specific strategies for advanced or recurrent solid tumors.
Thoracic and Gastrointestinal Oncology
Clinical interests include non-small cell lung cancer, small cell lung cancer, head and neck squamous cell carcinoma, gastric cancer, colorectal cancer, pancreatic cancer, and biliary tract cancer, covering both lung and digestive system malignancies.
- Non-small cell lung cancer
- Small cell lung cancer
- Colorectal cancer
- Pancreatic cancer
Research in this field supports the evaluation of targeted and immune-based therapies across advanced thoracic and gastrointestinal cancers.
Hematologic Malignancies and Cellular Therapy
Another major area of interest is hematologic malignancies, including multiple myeloma, acute myeloid leukemia, chronic lymphocytic leukemia, diffuse large B-cell lymphoma, follicular lymphoma, and mantle cell lymphoma, as well as graft-versus-host disease.
- Multiple myeloma
- Acute myeloid leukemia
- Chronic lymphocytic leukemia
- Diffuse large B-cell lymphoma
The portfolio also includes post-transplant and cellular therapy-related care, highlighting involvement in innovation for difficult-to-treat blood cancers.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.